Date:   1/22/2007 5:30:09 PM ( 17 y ago)
Hits:   1,643
URL:   https://www.curezone.org/forums/fm.asp?i=817508

Re:
"
No, most aren't that naive (I hope)
"

I wish this were true. But when 64% of scientists at the FDA itself back in 2004 believed they were doing the right thing while 66% of them knew or suspected that the safety of meds wasn't being properly observed, imagine the percentages in the country itself today:


--Excerpt--
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .


http://www.redorbit.com/news/display?id=111841


Posted on: Thursday, 16 December 2004, 15:00 CST
Survey Shows Lack of Confidence at FDA

WASHINGTON -- About two-thirds of Food and Drug Administration scientists are less than fully confident in the agency's monitoring of the safety of prescription drugs now being sold, according to an FDA internal survey.

And more than a third have some doubts about the process for approving new drugs, the survey found.

The survey was conducted by the Department of Health & Human Services Office of Inspector General, but the full results were released to the public only after an advocacy group filed a Freedom of Information Act petition. It comes in the wake of safety concerns forcing removal from the market of Vioxx, an Arthritis drug, and congressional testimony by Dr. David Graham, an FDA scientist, that the agency mishandled safety concerns about five other drugs.

"By all appearances, FDA would rather be sorry than safe," said Rebecca Roose, director of the Public Employees for Environmental Responsibility, an advocacy group that obtained the survey through a FOIA application. "These results show that many of Dr. Graham's colleagues share his concerns, but that those warnings are falling on deaf ears."

An FDA spokesman had no immediate response to a request for comment on the survey.

The survey sought the opinion of about 400 FDA scientists about the process of evaluating and approving prescription drugs. A majority of the scientists said they were "completely confident" or "mostly confident" about the FDA decisions about the safety and efficacy of drugs approved for sale. However, nearly a third, 31 percent, were only "somewhat confident" and five percent had no confidence in the safety decisions.

About 66 percent of the experts surveyed said they were not at all confident or only somewhat confident that the FDA adequately monitors the safety of prescription drugs once they are on the market.

"The survey raises significant issues about drug safety and ongoing monitoring of adverse health impacts of drugs in the marketplace," said Kathleen Rest, executive director of the Union of Concerned Scientists, a group that posted the full survey on its Web site. "The scientists' concerns warrant further investigation as Congress reviews drug approval practices at FDA."
. . . . . . . . . . . . . . . . . . . . . . . . . . . . .




This is when one simply must WONDER.
 

<< Return to the standard message view

fetched in 0.02 sec, referred by http://www.curezone.org/forums/fmp.asp?i=817508